Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026, Jul 2026, Aug 2026 and Sep 2026.
- Largest single sale: $2.7M (104,124 shares) of Mineralys Therapeutics, Inc. on Jun 26, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Mar 4, 2026 | Sep 22, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 21, 2026, Mineralys Therapeutics, Inc.: sold 7,438 shares for $209K, under a disclosed plan; 7,438 shares acquired by exercising options. 1 filing: 1
- Aug 21, 2026, Mineralys Therapeutics, Inc.: sold 7,437 shares for $193K, under a disclosed plan; 7,437 shares acquired by exercising options. 1 filing: 1
- Jul 21, 2026, Mineralys Therapeutics, Inc.: sold 7,438 shares for $200K, under a disclosed plan; 7,438 shares acquired by exercising options. 1 filing: 1
- Jun 26, 2026, Mineralys Therapeutics, Inc.: sold 104,124 shares for $2.7M, under a disclosed plan; 104,124 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.